KMLE
»çÀÌÆ® ¼Ò°³
°Ë»ö
°Ë»ö¾î Áö¿ì±â
´Ý±â
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
°í±Þ °Ë»ö ¼³Á¤
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú :
14
ÆäÀÌÁö:
8
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿¥.ºêÀÌ.¿¡ÃëÁÖ
Retinol Palmitate 6.65 , Ergocalciferol 25 , Tocopherol Acetate 5 , As...
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
1422¿ø/5 °³
·Î¶ó¹ÝÁ¤0.5mg
Lorazepam 500 ¥ìg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
20¿ø/1 °³
·Î¶ó¹ÝÁ¤1mg
Lorazepam 1 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
23¿ø/1 °³
ȯÀο°»êÀ̹ÌÇÁ¶ó¹ÎÁ¤25mg
Imipramine HCl 25 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
31¿ø/1 °³
¿¥ºêÀÌ¿¡ÃëÁÖ
Retinol Palmitate 10000 , Thiamine HCl 10 , Riboflavin Sodium Phosphat...
ȯÀÎÁ¦¾à
Àü¹®|»èÁ¦
0¿ø/5 °³
Æä¸®µ¹ÁÖ
Haloperidol 5 mg/mL
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
300¿ø/1 °³
Æä¸®µ¹Á¤10mg
Haloperidol 10 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
106¿ø/1 °³
ȯÀγª·Ï¼ÕÁÖ0.4mg
Naloxone HCl 400 ¥ìg/mL
ȯÀÎÁ¦¾à
Àü¹®|»èÁ¦
0¿ø/1 °³
¿¡ÇÊ·¾ÅçÁ¤200mg
Carbamazepine 200 mg
ȯÀÎÁ¦¾à
Àü¹®|»èÁ¦
0¿ø/1 °³
¾ÆÅ°½ÅÁÖ»ç¾×500mg
Amikacin Sulfate 500
ȯÀÎÁ¦¾à
Àü¹®|»èÁ¦
0¿ø/1 °³
ºÎ¸®µ¹Á¤5mg
Bromperidol 5 mg
ȯÀÎÁ¦¾à
Àü¹®|»èÁ¦
0¿ø/1 °³
ȯÀο°»êŬ·Î¹ÌÇÁ¶ó¹Îĸ½¶10mg
Clomipramine HCl 10 mg
ȯÀÎÁ¦¾à
Àü¹®|»èÁ¦(ºñ±Þ¿©Àüȯ)
0¿ø/1 °³
ȯÀο°»êŬ·Î¹ÌÇÁ¶ó¹Îĸ½¶25mg
Clomipramine HCl 25 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
101¿ø/1 °³
Æä¸®µ¹Á¤20mg
Haloperidol 20 mg
ȯÀÎÁ¦¾à
Àü¹®|±Þ¿©
212¿ø/1 °³
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
critically ill patient
ÁßȯÀÚ
cross circulation
±³Â÷¼øÈ¯
crossingover
±³Â÷, ±³¹è, À¯ÀüÀÚ±³È¯
cryptorchid
Àẹ°íȯ-
cryptorchidectomy
Àẹ°íȯÀýÁ¦(¼ú)
cryptorchidism
Àẹ°íȯ(Áõ)
cryptorchidopexy
°íȯ°íÁ¤(¼ú)
cryptorchism
Àẹ°íȯ(Áõ)
cutaneous hallucination
ÇǺÎȯ°¢
cycle
1. ÁÖ±â 2. ¼øÈ¯ 3. ȸ·Î 4. °í¸® 5. Á֯ļö
cyclic
ÁÖ±â-, ¼øÈ¯-, ȸ·Î-, °í¸®-
cyclic periodicity
¼øÈ¯Áֱ⼺
cyclic schizophrenia
¼øÈ¯ÇüÁ¤½ÅºÐ¿º´
cycling
¼øÈ¯¼º
cycloid
¼øÈ¯Çü-
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
8
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ventilator
1.ȯ±â±â, 2.ÀΰøÈ£Èí±â
vaginalitis
°íȯÁý¸·¿°
alveolar ventilation
ÆóÆ÷ȯ±â, ÇãÆÄ²Ê¸®È¯±â
circulating blood volume
¼øÈ¯Ç÷¾×·®
dead space ventilation
Á×Àº°ø°£È¯±â, »ç°È¯±â
noninvasive positive-pressure ventilation
ºñħ½À¾ç¾Ðȯ±â
pressure-controlled ventilation
¾Ð·ÂÁ¶Àýȯ±â
testicular varicocele
°íȯÁ¤¸Æ·ù
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
2
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
phantosmia
ȯÃë, ȯ»ó³¿»õ
annelid
ȯÇüµ¿¹°
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
commutator series
±³È¯ÀÚ¿
compensatory circulation
(¢¡collateral circulation) °ç¼øÈ¯
congenital conversion nipple
¼±ÃµÀüȯÀ¯µÎ
continuous mandatory ventilation
Áö¼ÓÇʼöȯ±â
control mode ventilation
Á¶Àýȯ±â¹ý
controlled mechanical ventilation
±â°èÀûÁ¶Àýȯ±â
conversion disorder
ÀüȯÀå¾Ö, Àüȯº´
conversion factor
º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
conversion heat
Àüȯ¿
conversion neurosis
Àüȯ½Å°æÁõ
conversion rate
ÀüȯÀ²
conversion reaction
Àüȯ¹ÝÀÀ
conversion voice disorder
ÀüȯÀ½¼ºÀå¾Ö
converting enzyme inhibitor
Àüȯȿ¼Ò¾ïÁ¦Á¦
coronary circulation
½ÉÀ嵿¸Æ¼øÈ¯
ÀÌÀü
´ÙÀ½
Sponsored Links
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
angiotensin converting enzyme
¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò.
angiotensin converting enzyme inbibitor
¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦¹°Áú<¾à>.
angiotensin converting enzyme inhibitor
¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦¹°Áú<¾à>.
angiotensin-converting enzyme
¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò
anion exchange chromatography
À½À̿±³È¯Å©·Î¸¶Åä±×·¡ÇÇ
anion exchange protein
À½À̿ ±³È¯ ´Ü¹é(ÎßüµÓ±ÛÜ)
anion exchange resin
À½À̿±³È¯¼öÁö
anisometrope
±¼ÀýºÎµîȯÀÚ(¡ãÊü´íº).
annularis telangiectodes purpura
¸ð¼¼Ç÷°ü È®À强 ȯ»óÀÚ¹Ý
anomalies of systemic venous return
´ëÁ¤¸ÆÈ¯·ù(ÓÞð¡Øæü½êü)ÀÌ»ó.
anomalies of systemic venous return
´ëÁ¤¸ÆÈ¯·ù(ËÀ?ËÎÌ·Ëô)ÀÌ»ó.
anomalous pulmonary venous drainage
ÆóÁ¤¸ÆÈ¯·ù(øËð¡Øæü½êü)ÀÌ»ó.
anomalous pulmonary venous drainage
ÆóÁ¤¸ÆÈ¯·ù(̰?ËÎÌ·Ëô)ÀÌ»ó.
anomalous pulmonary venous return
ÆóÁ¤¸ÆÈ¯·ùÀÌ»ó.
anorchi(di)sm
¹«°íȯÁõ(ÙíÍÂü¯ñø).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
circular DNA
ȯ»ó DNA.
loop gap resonator
ȯ»ó °£°Ý °ø¸í±â
annular psoriasis
ȯ»ó °Ç¼±(ËëàÈ)
cyclarthrosis
ȯ»ó °üÀý(ü»ßÒμï½), Â÷Ãà °üÀý(ó³õîμï½).
circinate balanitis
ȯ»ó ±ÍµÎ¿°
circinate impetigo
ȯ»ó ³ó°¡Áø
circular bandage
ȯ»ó ºØ´ë(ü»ßÒÝÞÓá).
annular prurigo
ȯ»ó ¾çÁø
annular granuloma
ȯ»ó À°¾ÆÁ¾(ë¿ä´ðþ)
ring enhancement
ȯ»ó Á¶¿µÁõ°
annular lipoatrophy
ȯ»ó Áö¹æ À§ÃàÁõ(ëÌßÒ ò·Û¸ ê×õêñø)
annular elastotic giant cell granuloma
ȯ»ó ź·Â ¼¶À¯¼º °Å´ë¼¼Æ÷ À°¾ÆÁ¾
annular lichen planus
ȯ»ó ÆíÆò( ø·øÁ)ż±(÷ÄàÈ)
annular erythema
ȯ»ó È«¹Ý
trichobasiloma cysticum annulare ³ª
ȯ»ó(¼¼Æ÷)¸ð±âÀú¼¼Æ÷Á¾(ü»ßÒá¬øàÙ¾Ðñ î¼á¬øàðþ)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
aortic valvular disease
´ëµ¿¸ÆÆÇÁúȯ(¡òðü´).
aortism
´ëµ¿¸ÆÁúȯ(üÁú)(¡òðü´ô÷òõ).
aphasi(a)c
1. ½Ç¾î(Áõ)ÀÇ. 2. ½Ç¾îÁõȯÀÚ.
aphasic
½Ç¾îÁõÀÇ, ½Ç¾îÁõ ȯÀÚ
apotheter
Á¦´ëȯ³³±â(Á¦´ëȯ³³±â).
apparition
ȯ¿µ(ü³ç±)
appearance time
ÃâÇö½Ã°£(õóúÞãÁÊà) ¼øÈ¯(âàü») .
appendices epididymidis<³ª>
ºÎ°íȯµ¹±â.
appendix epididymidis
(ºÎ°íȯºÎ¼Ó¹°)
appendix epididymidis
ºÎ°íȯºÎ¼Ó¹°
appendix epididymis
ºÎ°íȯ¼ö
appendix of epididymis
(ºÎ°íȯºÎ¼Ó¹°)
appendix of testis
°íȯºÎ¼Ó¹°
appendix testis
°íȯ¼ö.
appendix testis
(°íȯºÎ¼Ó¹°)
ÀÌÀü
´ÙÀ½
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
1
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÇÑÀÚ
synchronized intermittent mandatory v., SIMV
µ¿½Ã°£Çæ°Á¦È¯±â
ÔÒãÁàõÊàúÎîÜËð¤üµÑ¨
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
oxane ring
¿Á¼¼ÀÎȯ(ü»)
oxidation-reduction enzyme
»êÈȯ¿ø È¿¼Ò(ß«ûùü½êªý£áÈ)
oxidation-reduction potential
»êÈȯ¿ø ÀüÀ§(ß«ûùü½êªï³êÈ)
oxidation-reduction reaction
»êÈȯ¿ø ¹ÝÀÀ(ß«ûùü½êªÚãëë)
oxidoreductase
"¿Á½Ãµµ¸®´ÚÅ×À̽º, »êÈȯ¿øÈ¿¼Ò(ß«ûùü½êªý£áÈ)"
oxidoreduction reaction
»êÈȯ¿ø¹ÝÀÀ(ß«ûùü½êªÚãëë)
permissible substitution
Çã¿ë ġȯ(úÉé»öÇüµ)
permutation
"¼ø¿(â÷æê), ±³È¯(Îßüµ)"
phage conversion
"ÆäÀÌÁö Àüȯ(ï®üµ), ÆäÀÌÁö º¯È¯(ܨüµ)"
Pompe's disease
ÆûÆä Áúȯ(òðü´)
precursor of serum prothrombin conversion accelerator
Ç÷û(úìôè)ÇÁ·ÎÆ®·Òºó Àüȯ°¡¼ÓÁ¦ Àü±¸¹°Áú(ï®üµÊ¥áÜð¥îñÏÌÚªòõ)
prophage-mediated conversion
ÇÁ·ÎÆäÀÌÁö ¸Å°³ Àüȯ(ØÚË¿ï®üµ)
protein turnover
´Ü¹éÁú Àüȯ(Ó±ÛÜòõï®üµ)
pyrophosphate exchange
ÆÄÀÌ·ÎÀλê(×òß«) ±³È¯(Îßüµ)
radical amino acid replacement
¶óµðÄ® ¾Æ¹Ì³ë»ê ġȯ(öÇüµ)
ÀÌÀü
´ÙÀ½
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
pulmonary circulation time
Æó¼øÈ¯½Ã°£
radiation sickness
¹æ»ç¼±Áúȯ
recycle
Àç¼øÈ¯
reduction
Á¤º¹, °¨¼Ò, ȯ¿ø
replacement
º¹À§, ġȯ
restrictive heart disease
±¸¼Ó¼º½ÉÁúȯ
restrictive lung disease
±¸¼Ó¼ºÆóÁúȯ
restrictive pulmonary disease
±¸¼Ó¼ºÆóÁúȯ
retained testicle
Á¤·ù°íȯ
rheumatic disease
·ù¸¶Æ¼½º¼ºÁúȯ
rheumatic heart disease
·ù¸¶Æ¼½º¼º½ÉÁúȯ
scan converter
½ºÄµº¯È¯ÀåÄ¡
signet-ring cell
¹ÝÁö¼¼Æ÷, ÀÎȯ¼¼Æ÷
spirochetal disease
½ºÇÇ·ÎÇìŸÁúȯ
substitution
ġȯ, ´ë¿ë, ´ëÄ¡
ÀÌÀü
´ÙÀ½
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
5
ÆäÀÌÁö:
8
ÄÚµå
¿µ¹®
ÇѱÛ
B95.2
Streptococcus, group D, as the cause of diseases classified to other chapters
´Ù¸¥ Àå¿¡¼ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼ÀÇ »ç½½¾Ë±Õ DÇ÷û±º
B95.3
Streptococcus pneumoniae as the cause of diseases classified to other chapters
´Ù¸¥ Àå¿¡¼ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼ÀÇ Æó·Å»ç½½¾Ë±Õ
B95.4
Other streptococcus as the cause of diseases classified to other chapters
´Ù¸¥ Àå¿¡¼ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼ÀÇ ±âŸ »ç½½¾Ë±Õ
B95.5
Unspecified streptococcus as the cause of diseases classified to other chapters
´Ù¸¥ Àå¿¡¼ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼ÀÇ »ó¼¼ºÒ¸íÀÇ »ç½½¾Ë±Õ
B95.6
Staphylococcus aureus as the cause of diseases classified to other chapters
´Ù¸¥ Àå¿¡¼ ºÐ·ùµÈ ÁúȯÀÇ ¿øÀÎÀ¸·Î¼ÀÇ È²»ö Æ÷µµ¾Ë±Õ
ÀÌÀü
´ÙÀ½
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
¼³¸í
cyclic AMP
ȯ»ó AMP, °í¸®¸ð¾ç AMP, ȯ½Ä ¾Æµ¥³ë½Å ¸ð³ëÆ÷½ºÆäÀÌÆ®, »çÀ̱۸¯ AMP, cAMP
cyclic adelenosine 3',5'-mono
cyclic AMP system
ȯ»ó AMP °è
cycloid personality
¼øÈ¯º´Áú¼º ÀΰÝ
cyclothmic
¼øÈ¯±âÁú¼º
cyclothymic personality
°¨Á¤ ¼øÈ¯¼º ÀΰÝ
delirium
¼¶¸Á, ȯ°¢, Âø°¢, ¸Á»ó, Çê¼Ò¸®
´ë³úÀÇ ÈïºÐ, ½ÅüÀûÀÎ ºÒ¾ÈÁ¤, »ç°í »ê¶õÀ» Ư¡À¸·Î ÇÏ´Â ºñ±³Àû ªÀº ±â°£ÀÇ Á¤½ÅÀû Àå¾Ö. ¼¶¸ÁÀº º¸Åë Áßµ¶ »óÅÂÀÇ ¹Ý¿µÀÌ´Ù.
deoxidizing
ȯ¿ø
ÈÇÐÀûÀ¸·Î °áÇÕµÈ »ê¼Ò¸¦ Á¦°ÅÇÏ´Â °Í.
dereism
ȯ»ó±¤, ºñÇö½Ç¼º
³í¸®¿Í üÇè¿¡ ÀÇÇØ ȯ»óÀÌ ¾ïÁ¦µÇÁö ¸øÇϰí ÀÚÀ¯·ÎÀÌ ³ªÅ¸³ª´Â Á¤½ÅÀû Ȱµ¿¼º.
desoxydation
ȯ¿ø, Å»»ê¼Ò
deuteropathy
2Â÷¼º Áúȯ, ÈĹßÁõ, ¼Ó¹ßÁõ, ¼Ó¹ß¼º Áúº´
diadochokinesia
±³´ë ¿îµ¿, ±æÇ× ¹Ýº¹, º¯È¯ ¿îµ¿, ±æÇ× ¿îµ¿ ¹Ýº¹
ÇϳªÀÇ ¿îµ¿ Ãæµ¿À» ÁßÁöÇÏ°í ±×°Í°ú Á¤¹Ý´ëÀÇ Ãæµ¿À¸·Î º¯°æÇÏ´Â ±â´É.
dichromat
ÀÌ»ö½Ã ȯÀÚ
ÀÌ»ö¼º »ö¸ÍÀÚ, ÀÌ»öÇü »ö°¢ÀÚ.
didymitis
°íȯ¿°
diphyodont
À̸¦ °¡´Â, ȯġÀÇ
Å»¶ô¼º°ú ¿µ±¸¼ºÀÇ µÎ °¡Áö Ä¡¿À» °¡Áø °Í.
disillusion
°¢¼º, ȯ¸ê
ÀÌÀü
´ÙÀ½
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú:
10
ÆäÀÌÁö:
8
³×Æ÷´ÏµåÁ¤10mg
A09703201
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Nemonapride
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
³×Æ÷´ÏµåÁ¤3mg
A09703191
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Nemonapride
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
¸ÞÇÁÁ¹Ä¸½¶
A09703561
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Omeprazole
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
¹Ù·»Å¹ÁÖ
A09701761
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Diclofenac sodium
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ
Æå½ÅÁ¤
A09702471
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Pefloxacin methanesulfonate
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | »èÁ¦
Æå½ÅÁÖ
A09702481
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Pefloxacin methanesulfonate
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | »èÁ¦
ÇÇÇÇÁ¬Á¤4mg
A09700371
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Perphenazine
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ¹Ì»ý»ê
ȯÀÎÇǸðÁþÁ¤1mg
A09701781
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Pimozide
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ¹Ì»ý»ê
ȯÀÎÇǸðÁþÁ¤4mg
A09701791
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Pimozide
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ¹Ì»ý»ê
ȯÀÎŰ´©ÇÁ¸±Á¤7.5mg
A09703151
ÆÇ¸Å»ç: ȯÀÎÁ¦¾à
¼ººÐ/ÇÔ·®: Quinupramine
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | »èÁ¦
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
fantastical
ȯ»óÀûÀÎ
jubilant
ȯ¼ºÀ» ¿Ã¸®´Â
laicize
ȯ¼Ó(¼ÓÈ)½ÃŰ´Ù;¼ÓÀο¡°Ô ¸Ã±â´Ù;(°øÁ÷ µîÀ»)¼ÓÀο¡°Ô °³¹æÇÏ´Ù
secularize
ȯ¼Ó½ÃŰ´Ù;¼Ó¿ëÀ¸·Î Á¦°øÇÏ´Ù;...À» Á¾±³¿¡¼ ºÐ¸®½ÃŰ´Ù
photism
ȯ½Ã
ingratiate
ȯ½ÉÀ» »ç´Ù
ingratiate
ȯ½ÉÀ» »ç´Ù;..ÀÇ ºñÀ§¸¦ ¸ÂÃß´Ù
make up to
ȯ½ÉÀ» »ç·Á°íÇÏ´Ù; Á¢±ÙÇÏ´Ù
pillbox
ȯ¾à °©;ÀÛÀº ¿ä»õ;Åäġī
pilular
ȯ¾àÀÇ
pilulous
ȯ¾àÀÇ
pilular
ȯ¾àÀÇ
stonehenge
ȯ¿¼®ÁÖ
phantasmagoric
ȯ¿µ °°Àº;ÁÖ¸¶µî°°ÀÌ º¯ÇÏ´Â
glad hand
ȯ¿µ(ÀÇ ¼Õ)
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
Benadryl
º£³ªµå¸±;(µÎµå·¯±â,¾Ë·¹¸£±â¼º Áúȯ¿ë)
Bikini
ºñŰ´ÏȯÃÊ(¸¶¼£ ±ºµµÀÇ);(ÅõÇǽºÀÇ)¿©ÀÚ ¼ö¿µº¹
CCU
communication control unit;coronary care unit °ü(»ó)Áúȯ ÁýÁß Ä¡·á º´µ¿
Canal Zone
ÆÄ³ª¸¶ ¿îÇÏ Áö´ë(2000³â¿¡ ¹Ì±¹ÀÌ ÆÄ³ª¸¶¿¡ ¹Ýȯ ¿¹Á¤)
Christmasbox
Å©¸®½º¸¶½º¼±¹°(ÃàÇϱÝ)(»çȯ.¿ìÆí Áý¹è¿øµî¿¡°Ô ÁÖ´Â)
Cockaigne
ȯ¶ô°æ;·±´ø
Collins
ȯ´ë¿¡ ´ëÇÑ ÀλçÀå;ÁøÀ» ź À½·á(ĬÅ×ÀÏÀÇ ÀÏÁ¾)
D/A converter
DAº¯È¯±â(µðÁöÅÐ ½ÅÈ£¸¦ ¾Æ³¯·Î±× ½ÅÈ£·Î º¯È¯)
DMT
dimethyltryptamine(ȯ°¢Á¦)
Dalai Lama
´Þ¶óÀ̶ó¸¶(Ƽº£Æ®ÀÇ È¯ºÒ)
Don Juan
µ·È¯;½ºÆäÀÎÀÇ ¹æÅÁÇÑ ±ÍÁ·
Dr,Feelgood
°¢¼ºÁ¦¸¦ Á¤±âÀûÀ¸·Î ¸Ô¿© ȯÀÚ¸¦ ±âºÐ ÁÁ°Ô ¸¸µå´Â ÀÇ»ç
ECLSS
environmental control and life support system;ȯ°æ Á¦¾î;»ý¸í À¯Áö ½Ã½ºÅÛ
ED
effectove dpse.(¾àÀÇ)À¯È¿·®;environmental disruption ȯ°æ ÆÄ±«
EPA
Environmental Protection Agency(¹Ì)ȯ°æ º¸È£Ã»
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
ÀÌÀü
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
8
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
8
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½